Novogene shares surge 20% on STAR Market, block trades total 26.95 million yuan on Sept 23
Novogene (Beijing Novogene Technology Co., Ltd.) saw its stock hit the daily limit on the Shanghai STAR Market on September 21, surging 20% to 18.18 yuan. Over three consecutive trading days (Sept 21-23), the company executed six block trades totaling approximately 78.66 million yuan, all at a discount to the closing price. The stock rose 40.92% over five days through September 23, with net main capital outflows of 85.38 million yuan during that period.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Common ground
- Both sides agree that the block trades were transparent and legal under CSRC rules.
- Both acknowledge the dragon-tiger list provides more public disclosure than many Western exchanges.
- Both recognize that the 40% stock surge was driven largely by retail momentum, not institutional buying.
- Both agree that the seller, SDIC Securities Jiangsu Branch, was systematically reducing its position over multiple days.
Points of contention
- Neutral Agent sees the block trades as a coordinated exit by a major shareholder into retail buying, while Eastern Agent views it as routine institutional repositioning within a pre-announced plan.
- Neutral Agent argues the 7% revenue growth and 20% net profit drop signal fundamental weakness, while Eastern Agent says this reflects strategic R&D investment for genomic independence.
- Neutral Agent warns that 37% margin debt growth in five days shows risky momentum-chasing, while Eastern Agent says the leverage ratio is below market average and normal.
- Neutral Agent points to the consistent single-counterparty block trade pattern as suspicious, while Eastern Agent says that's standard execution under CSRC matching rules.
Blind spots
- Both sides overlooked the possibility that the block trade discount increase from 0.72% to 0.78% could indicate seller urgency, not just a rounding error.
- Neither side fully addressed the absence of insider buying during the surge, though Neutral Agent later conceded blackout periods may explain it.
- The debate missed analyzing how Novogene's cost of revenue growth specifically relates to domestic platform investments versus other operational factors.
- Both sides failed to consider the impact of broader market sentiment or sector-wide trends on the stock's price movement.
WorldAttention’s read
After a thorough debate, the key takeaway is that Novogene's block trades and stock surge reflect a clash between two valid perspectives. Neutral Agent correctly identifies a classic distribution pattern—smart money selling into retail enthusiasm, with margin debt growing fast and fundamentals not supporting the valuation. Eastern Agent rightly points out that China's capital markets are transparent and that Novogene's strategic role in genomic independence justifies forward-looking pricing, even if current profits are squeezed by investment. The truth likely lies in the middle: the block trades are legal and orderly, but retail investors should be cautious about chasing a stock where insiders are exiting and margins are under pressure. The geopolitical narrative is real, but it doesn't override basic financial math in the short term.
Reporting timeline
Novogene Reports Two Block Trades Totaling 26.95 Million Yuan on September 23
On September 23, Novogene (Beijing Novogene Technology Co., Ltd.) executed two block trades totaling 26.95 million yuan, according to data from Securities Times. Each trade involved 700,000 shares at a price of 19.25 yuan per share, representing a 0.72% discount to the closing price of 19.39 yuan. The buyers were China Securities Co., Ltd. and a dedicated institutional account, while the seller was Guotai Junan Securities Jiangsu Branch. Over the past three months, Novogene has completed seven block trades with a combined value of 86.7187 million yuan. The stock rose 1.95% on the day with a turnover rate of 6.63% and trading volume of 526 million yuan. Main capital saw a net outflow of 41.6023 million yuan, and over the past five days the stock has surged 40.92% with a total net capital outflow of 85.3825 million yuan. Margin trading balance increased by 51.0197 million yuan (37.26%) over five days to 188 million yuan. The company, founded on March 15, 2011, has a registered capital of 416.2 million yuan.
Novogene Reports Two Block Trades Totaling 26.95 Million Yuan
On September 23, Novogene (Beijing Novogene Technology Co., Ltd.) executed two block trades totaling 1.4 million shares with a combined value of 26.95 million yuan. Both trades were priced at 19.25 yuan per share, a 0.72% discount to the closing price. One trade involved a buyer from China Securities Co., Ltd. headquarters and the other from an institutional special account, both with the seller being SDIC Securities Co., Ltd. Jiangsu Branch. The institutional account net purchased 13.475 million yuan. Over the past three months, Novogene has completed seven block trades totaling 86.7187 million yuan. The stock closed at 19.39 yuan, up 1.95%, with a turnover rate of 6.63% and trading volume of 526 million yuan. Main capital saw a net outflow of 41.6023 million yuan on the day, and over five days the stock rose 40.92% with a net capital outflow of 85.3825 million yuan. Margin trading balance increased by 51.0197 million yuan (37.26%) over five days to 188 million yuan. The company was founded on March 15, 2011, with a registered capital of 416.2 million yuan.
Read sourceNovogene Co. Sees Two Block Trades Totaling 26.44 Million Yuan on September 22
On September 22, Novogene Co., Ltd. (Novogene) executed two block trades totaling 26.443 million yuan, according to data from Securities Times. The trades involved 700,000 shares each at a price of 18.88 yuan per share, representing a 0.74% discount to the closing price. The seller was Guotou Securities Jiangsu Branch, with buyers being China Securities Co. and an institutional account. The stock closed at 19.02 yuan, up 4.62% on the day, with a turnover rate of 11.87% and trading volume of 956 million yuan. Main capital saw a net outflow of 88.89 million yuan for the day. Over the past five trading days, the stock has surged 43.12%, with total net capital outflow of 40.79 million yuan. Margin trading balance stood at 142 million yuan, up 4.20 million yuan (3.05%) over five days. The company, founded on March 15, 2011, has a registered capital of 416.2 million yuan.
Show 3 older updatesHide older updates
Novogene Reports 2 Block Trades Worth 25.27 Million Yuan on September 21
On September 21, Novogene (Beijing Novogene Technology Co., Ltd.) executed two block trades totaling 1.4 million shares with a combined value of 25.27 million yuan. Both trades were priced at 18.05 yuan per share, representing a 0.72% discount to the day's closing price of 18.18 yuan. One trade involved a China Securities Co. institutional account buying 70.00 million shares worth 12.635 million yuan from a seller via Guosen Securities Jiangsu branch, while the other trade was between China Securities Co. headquarters and the same seller. Over the past three months, Novogene has completed three block trades totaling 33.3367 million yuan. The stock surged 20% on the day with a turnover rate of 4.30% and net main capital inflow of 42.5344 million yuan. Over the past five days, the stock has risen 33.97% with net capital inflow of 48.6893 million yuan. Margin balance stood at 146 million yuan, up 3.40% in five days. The company was founded on March 15, 2011, with a registered capital of 416.2 million yuan.
Read sourceNovogene's Dragon and Tiger List Shows Net Purchase of 7.5249 Million Yuan by Brokerage
On September 21, Novogene (stock code) appeared on the 'Dragon and Tiger List' (a Chinese stock exchange disclosure for heavily traded stocks). According to data from Securities Times, the top five buying and selling brokerage departments on the list had a total turnover of 210 million yuan. The total buy-side amount was 109 million yuan, while the sell-side amount was 101 million yuan, resulting in a net purchase of 7.5249 million yuan. Among the top five buying departments, Huaxin Securities Shanghai Lujiazui led with 30.8015 million yuan in purchases, followed by the Shanghai-Hong Kong Stock Connect special account with 27.9047 million yuan. On the sell side, SDIC Securities Jiangsu Branch was the largest seller, offloading 75.6652 million yuan. The Shanghai-Hong Kong Stock Connect account was the third-largest seller, with sales of 6.5244 million yuan, but overall it recorded a net purchase of 21.3803 million yuan for the stock. The stock saw a net inflow of 42.5344 million yuan in main capital for the day.
Novogene Stock Hits Daily Limit on STAR Market, Shares Surge 20%
On September 21, Novogene (stock code: 688315) hit the daily trading limit on the Shanghai Stock Exchange's STAR Market, with shares surging 20% to 18.18 yuan as of 09:34 Beijing time. Trading volume reached 112 million yuan with a turnover rate of 1.54% and an amplitude of 11.62%. Among STAR Market stocks, 495 were rising and 115 falling, with Novogene leading the gainers. The company's main funds saw a net inflow of 5.8375 million yuan on the previous trading day and 13.121 million yuan over the past five days. Margin trading data as of September 18 showed a balance of 146 million yuan, with margin balance increasing by 10.7982 million yuan (8.01%) from the previous day. The company's semi-annual report released on August 26 revealed revenue of 1.114 billion yuan in the first half, up 7.09% year-on-year, but net profit fell 19.82% to 63.1226 million yuan. The report notes this is a news article and not investment advice.
Read source